National HealthCare Corporation
AMEX:NHCMedical - Care Facilities
+$1.33 today
- Market cap
- $3.16B
- Beta
- 0.67
- P/E (TTM)
- 24.2
- EPS (TTM)
- $7.96
- Dividend yield
- 1.33%
Volume 0.10M
Average 0.12M
NHC Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
National HealthCare CorporationAMEX: NHC
Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026
Cost of revenue growth accelerates
Q3 FY2026 cost of revenue of $367.34M rose 57.5% year over year, ahead of the +16.9% change in trailing-twelve-month cost of revenue. Sequentially, it rose 51.9% from the prior quarter. Over 3 fiscal years it compounded at +10.3% a year.
Context
- Cost of revenue amounted to 60.7% of revenue in FY2025, down 1.8 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +57.5% holds above the trailing-twelve-month pace of +16.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 921.08M USD
- Year-over-year change
- +13.6%
- 4-year CAGR
- +8.4%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 921.08M | +13.6% |
| FY2024 | 2024-12-31 | 810.93M | +13.8% |
| FY2023 | 2023-12-31 | 712.34M | +3.8% |
| FY2022 | 2022-12-31 | 686.17M | +3.0% |
| FY2021 | 2021-12-31 | 666.06M | — |
Cost of Revenue vs competitors
How NHC compares with its peers on the latest reported figures
- NHC's LTM Sep 2026 cost of revenue of $1.08B is the 6th highest of the 10 companies compared; the peer median is $1.81B.
- Its year-over-year change of +16.9% is the 5th highest of 10, against a peer median of +16.3%.
- Cost of revenue amounts to 68.0% of revenue for NHC, versus a peer median of 79.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $4.71B | +21.3% | +19.3% | 85.9% | |
| LTM Jun 2026 | $3.48B | +6.6% | +9.1% | 56.1% | |
| LTM Sep 2026 | $2.52B | +11.2% | +3.6% | 85.5% | |
| LTM Oct 2026 | $1.82B | +19.3% | +9.7% | 67.9% | |
| LTM Jun 2026 | $1.81B | +8.3% | +9.0% | 69.6% | |
| LTM Sep 2026 | $1.08B | +16.9% | +10.3% | 68.0% | |
| LTM Jun 2026 | $998.65M | +16.3% | +13.8% | 67.6% | |
| LTM Mar 2026 | $871.95M | +35.1% | +25.8% | 85.2% | |
| LTM Mar 2026 | $749.65M | +9.8% | -21.8% | 79.3% | |
| LTM Mar 2026 | $534.91M | +7028.0% | +146.8% | 129.9% | |
| Peer median (excluding NHC) | $1.81B | +16.3% | +9.7% | 79.3% | |
Competitors are the stored peer set for NHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.01B | 1.07B | 1.14B | 1.3B | 1.52B |
| Cost of Revenue | 666.06M | 686.17M | 712.34M | 810.93M | 921.08M |
| Gross Profit | 344.88M | 388.11M | 429.2M | 487.01M | 596.7M |
| Gross Margin | 34.1% | 36.1% | 37.6% | 37.5% | 39.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 40.82M | 40.98M | 41.53M | 43.18M | 46.23M |
| Operating Expenses | 293.95M | 356.22M | 372.07M | 401.25M | 468.35M |
| Depreciation & Amortization | 40.67M | 40.49M | 42.03M | 41.99M | 44.92M |
| EBITDA | 191.56M | 68.28M | 131.1M | 182.53M | 213.72M |
| EBITDA Margin | 18.9% | 6.4% | 11.5% | 14.1% | 14.1% |
| Operating Income | 50.93M | 31.9M | 57.13M | 85.76M | 128.35M |
| Operating Margin | 5.0% | 3.0% | 5.0% | 6.6% | 8.5% |
| Interest Income | 4.67M | 5.13M | 8.38M | 10.1M | 9.84M |
| Interest Expense | 845K | 563K | 324K | 4.14M | 6.37M |
| Other Income / Expenses | 99.11M | (4.67M) | 31.6M | 50.65M | 34.08M |
| Income Before Tax | 150.04M | 27.23M | 88.74M | 136.41M | 162.43M |
| Pre-Tax Margin | 14.8% | 2.5% | 7.8% | 10.5% | 10.7% |
| Income Tax Expense | 10.95M | 7.25M | 23.45M | 34.32M | 39.83M |
| Net Income | 138.59M | 22.45M | 66.8M | 101.93M | 120.02M |
| Net Margin | 13.7% | 2.1% | 5.9% | 7.9% | 7.9% |
| EPS (Basic) | 9.03 | 1.46 | 4.36 | 6.62 | 7.76 |
| EPS (Diluted) | 8.99 | 1.45 | 4.34 | 6.53 | 7.67 |
| Weighted Avg Shares | 15.35M | 15.41M | 15.31M | 15.39M | 15.47M |
| Weighted Avg Shares (Diluted) | 15.42M | 15.45M | 15.38M | 15.6M | 15.65M |
National HealthCare Corporation
AMEX:NHC
Intrinsic Alpha fair value
Locked
Current Price
$201.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.